Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Additional phase III data in support of TTFC

March 10, 2004

Alrex safe for long-term treatment of seasonal allergic conjunctivitis

Feb. 24, 2004

Senju claims new chymase and/or tryptase inhibitors and their use

Feb. 11, 2004

Extension to Vitrase NDA review

Feb. 10, 2004

Inspire to conduct additional trial for diquafosol following FDA meeting

Feb. 4, 2004

Phase III data for a fixed travoprost/timolol combination in glaucoma

Jan. 29, 2004

Novel EP4 agonists with utility in glaucoma and bone disorders

Jan. 23, 2004

Santen and Asahi Glass claim new prostaglandin analogues for glaucoma and other ocular disorders

Jan. 22, 2004

AFP-168, a novel ocular hypotensive candidate

Jan. 20, 2004

International pivotal Trabio study completes enrollment

Jan. 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...